HHS Secretary Alex Azar has appointed two advisors to help advance Department strategy to address prescription drug pricing and the opioid crisis. Daniel M. Best, the new Senior Advisor to the Secretary for Drug Pricing Reform, is charged with leading the HHS initiative to lower the cost of prescription drugs. He recently served as Corporate Vice President of Industry Relations for CVS Health's Medicare Part D business. In addition, Brett Giroir, M.D. has been named Senior Advisor to the Secretary for Mental Health and Opioid Policy, a role he will fill while continuing to serve as Assistant Secretary for Health. Secretary Azar also intends to name special advisors for healthcare payment reform and value-based transformation of the healthcare system in the coming weeks.
This article is presented for informational purposes only and is not intended to constitute legal advice.
